Literature DB >> 7504739

Apoptosis induced in CD4+ cells expressing gp160 of human immunodeficiency virus type 1.

Y Y Lu1, Y Koga, K Tanaka, M Sasaki, G Kimura, K Nomoto.   

Abstract

In a previous study (Y. Koga, M. Sasaki, H. Yoshida, H. Wigzell, G. Kimura, and K. Nomoto, J. Immunol. 144:94-102, 1990), we demonstrated that the expression of gp160, a precursor form of envelope glycoprotein of human immunodeficiency virus type 1, in CD4+ cells causes the downregulation of surface CD4 and single-cell killing by forming intracellular gp160-CD4 complex. In the present study we investigated the events that lead to cell death in CD4+ cells expressing gp160. We found that apoptosis is induced in cells undergoing single-cell death. Moreover, even the cell clone, which expresses so little gp160 that it does not exhibit any apparent cytopathic effects, such as the inhibition of cell growth, was found to be highly susceptible to the apoptosis induction by the anti-Fas monoclonal antibody.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7504739      PMCID: PMC236299     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1.

Authors:  C Terai; R S Kornbluth; C D Pauza; D D Richman; D A Carson
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

2.  Disturbance of nuclear transport of proteins in CD4+ cells expressing gp160 of human immunodeficiency virus.

Authors:  Y Koga; M Sasaki; H Yoshida; M Oh-Tsu; G Kimura; K Nomoto
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

3.  Cytopathic effect determined by the amount of CD4 molecules in human cell lines expressing envelope glycoprotein of HIV.

Authors:  Y Koga; M Sasaki; H Yoshida; H Wigzell; G Kimura; K Nomoto
Journal:  J Immunol       Date:  1990-01-01       Impact factor: 5.422

4.  The cytopathic effect of HIV is associated with apoptosis.

Authors:  A G Laurent-Crawford; B Krust; S Muller; Y Rivière; M A Rey-Cuillé; J M Béchet; L Montagnier; A G Hovanessian
Journal:  Virology       Date:  1991-12       Impact factor: 3.616

Review 5.  Apoptosis.

Authors:  J J Cohen
Journal:  Immunol Today       Date:  1993-03

6.  Anti-Fas monoclonal antibody is cytocidal to human immunodeficiency virus-infected cells without augmenting viral replication.

Authors:  N Kobayashi; Y Hamamoto; N Yamamoto; A Ishii; M Yonehara; S Yonehara
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

7.  Death of mature T cells by separate ligation of CD4 and the T-cell receptor for antigen.

Authors:  M K Newell; L J Haughn; C R Maroun; M H Julius
Journal:  Nature       Date:  1990-09-20       Impact factor: 49.962

8.  Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS.

Authors:  J Embretson; M Zupancic; J L Ribas; A Burke; P Racz; K Tenner-Racz; A T Haase
Journal:  Nature       Date:  1993-03-25       Impact factor: 49.962

9.  HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease.

Authors:  G Pantaleo; C Graziosi; J F Demarest; L Butini; M Montroni; C H Fox; J M Orenstein; D P Kotler; A S Fauci
Journal:  Nature       Date:  1993-03-25       Impact factor: 49.962

10.  Simultaneous analysis of immunophenotype and apoptosis of murine thymocytes by single laser flow cytometry.

Authors:  A B Lyons; K Samuel; A Sanderson; A H Maddy
Journal:  Cytometry       Date:  1992
View more
  37 in total

1.  Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection.

Authors:  Wei Jiang; Michael M Lederman; Peter Hunt; Scott F Sieg; Kathryn Haley; Benigno Rodriguez; Alan Landay; Jeffrey Martin; Elizabeth Sinclair; Ava I Asher; Steven G Deeks; Daniel C Douek; Jason M Brenchley
Journal:  J Infect Dis       Date:  2009-04-15       Impact factor: 5.226

Review 2.  Uses of flow cytometry in virology.

Authors:  J J McSharry
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

Review 3.  Role of the Fas/Fas ligand apoptotic pathway in human immunodeficiency virus type 1 disease.

Authors:  D Kaplan; S Sieg
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

4.  Apoptosis induction by the binding of the carboxyl terminus of human immunodeficiency virus type 1 gp160 to calmodulin.

Authors:  H Ishikawa; M Sasaki; S Noda; Y Koga
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

5.  Possible involvement of double-stranded RNA-activated protein kinase in cell death by influenza virus infection.

Authors:  T Takizawa; K Ohashi; Y Nakanishi
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

6.  The transmembrane domains of Sindbis virus envelope glycoproteins induce cell death.

Authors:  A K Joe; H H Foo; L Kleeman; B Levine
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

Review 7.  Immune dysregulation and CD4+ T cell loss in HIV-1 infection.

Authors:  L Meyaard; F Miedema
Journal:  Springer Semin Immunopathol       Date:  1997

8.  The vpu protein of human immunodeficiency virus type 1 plays a protective role against virus-induced apoptosis in primary CD4(+) T lymphocytes.

Authors:  Satoshi Komoto; Shoutaro Tsuji; Madiha S Ibrahim; Yong-Gang Li; Jiranan Warachit; Koki Taniguchi; Kazuyoshi Ikuta
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

9.  Apoptosis of bystander T cells induced by human immunodeficiency virus type 1 with increased envelope/receptor affinity and coreceptor binding site exposure.

Authors:  Geoffrey H Holm; Chengsheng Zhang; Paul R Gorry; Keith Peden; Dominique Schols; Erik De Clercq; Dana Gabuzda
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

10.  Bc1-2 protects mice against fatal alphavirus encephalitis.

Authors:  B Levine; J E Goldman; H H Jiang; D E Griffin; J M Hardwick
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.